Milestone Pharmaceuticals... (MIST)
1.97
0.01 (0.51%)
At close: Jan 15, 2025, 3:59 PM
1.98
0.51%
After-hours Jan 15, 2025, 04:12 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -1.2 | -2.94 | -6.43 | -3.93 | -4.58 | -15.68 | -44.95 |
| PS Ratio | 71.74 | 33.62 | 18.27 | n/a | n/a | n/a | n/a |
| PB Ratio | 4.28 | 2.53 | 2.43 | 1.37 | 2.20 | -6.58 | -10.97 |
| P/FCF Ratio | -1.54 | -3.19 | -8.25 | -3.88 | -4.9 | -17.27 | -44.94 |
| P/OCF Ratio | -1.55 | -3.2 | -8.25 | -3.88 | -4.94 | -17.27 | -45.14 |
| OCF/S Ratio | -46.42 | -10.49 | -2.21 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 3.09 | 0.04 | 0.01 | 0.01 | 0.00 | n/a | n/a |
| Quick Ratio | 10.11 | 11.75 | 17.61 | 24.26 | 14.78 | 19.42 | 17.17 |
| Current Ratio | 10.11 | 11.70 | 17.55 | 24.14 | 14.71 | 19.42 | 17.17 |
| Asset Turnover | 0.01 | 0.07 | 0.13 | n/a | n/a | n/a | n/a |
| Interest Coverage | -23.92 | n/a | n/a | -69.85 | -22.3 | n/a | n/a |
| Return on Equity (ROE) | -3.56 | -0.86 | -0.38 | -0.35 | -0.48 | 0.42 | 0.24 |
| Return on Assets (ROA) | -0.79 | -0.77 | -0.36 | -0.33 | -0.45 | -0.26 | -0.29 |
| Return on Capital (ROIC) | -0.9 | -0.87 | -0.38 | -0.35 | -0.5 | -0.29 | -0.32 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 90.40% | 100.00% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -5.97K% | -1.14K% | -284.22% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -5.97K% | -1.17K% | -285.69% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -6.11K% | -1.19K% | -287.15% | n/a | n/a | n/a | n/a |
| FCF Margin | -4.65K% | -1.05K% | -221.49% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -5.68K% | -1.17K% | -286.53% | n/a | n/a | n/a | n/a |